Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.23 trillion and total revenue of $116.49 billion.
Market Cap
1.23T
Revenue
116.49B
Profits
-35.33B
PE Ratio
n/a
Profit Margin
-30.33%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 126.35B | 2.74% | 2,053,192 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 90.35B | 4.65% | 16,683,152 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 77.72B | 3.35% | 877,499 | 15.53B |
| 4 | ARGX | argenx SE | 51.29B | 1.95% | 463,672 | 5.32B |
| 5 | RVMD | Revolution Medicines, Inc. | 41.48B | 2.70% | 2,462,577 | - |
| 6 | ONC | BeOne Medicines AG | 39.96B | 0.69% | 284,420 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 33.91B | 4.26% | 2,757,530 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.04B | 0.29% | 1,105,306 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 24.28B | 0.81% | 4,293,631 | 7.53M |
| 10 | INCY | Incyte Corporation | 22.61B | 2.72% | 1,866,960 | 5.82B |
| 11 | BNTX | BioNTech SE | 22.27B | -0.39% | 1,129,432 | 3.03B |
| 12 | GMAB | Genmab A/S | 22.25B | 0.88% | 2,686,846 | 4.13B |
| 13 | INSM | Insmed Incorporated | 21.36B | 1.03% | 2,735,632 | 1.14B |
| 14 | EXEL | Exelixis, Inc. | 15.11B | 2.49% | 2,730,459 | 2.44B |
| 15 | ASND | Ascendis Pharma A/S | 14.91B | 1.70% | 995,632 | 1.20B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 13.61B | -0.35% | 899,820 | 4.60B |
| 17 | HALO | Halozyme Therapeutics, Inc. | 13.26B | 6.57% | 3,786,242 | 1.66B |
| 18 | BBIO | BridgeBio Pharma, Inc. | 12.70B | 2.59% | 2,700,454 | 713.07M |
| 19 | CORT | Corcept Therapeutics Incorporated | 12.56B | -1.33% | 561,328 | 830.81M |
| 20 | SMMT | Summit Therapeutics Inc. | 12.10B | -2.51% | 4,652,661 | - |
| 21 | TECH | Bio-Techne Corporation | 11.37B | 0.03% | 1,544,768 | 1.22B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.67B | 1.40% | 1,845,376 | 3.41B |
| 23 | PCVX | Vaxcyte, Inc. | 10.63B | 1.12% | 1,524,846 | - |
| 24 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.63B | 1.72% | 326,937 | 1.28B |
| 25 | IBRX | ImmunityBio, Inc. | 10.50B | 1.12% | 29,767,580 | 165.79M |
| 26 | KRYS | Krystal Biotech, Inc. | 9.79B | 2.97% | 276,207 | 440.48M |
| 27 | TWST | Twist Bioscience Corporation | 9.29B | -2.09% | 2,113,810 | 431.80M |
| 28 | KYMR | Kymera Therapeutics, Inc. | 8.88B | 0.14% | 1,025,575 | 105.00M |
| 29 | CYTK | Cytokinetics, Incorporated | 8.82B | 2.99% | 2,095,715 | 67.67M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 8.82B | -1.60% | 679,029 | 281.99M |
| 31 | CAI | Caris Life Sciences, Inc. | 8.55B | 2.46% | 4,344,361 | 989.61M |
| 32 | AXSM | Axsome Therapeutics, Inc. | 8.50B | 3.75% | 874,900 | 776.57M |
| 33 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.25B | 0.41% | 4,158,202 | 669.50M |
| 34 | ABVX | ABIVAX Société Anonyme | 7.84B | 2.04% | 1,126,245 | 5.33M |
| 35 | TGTX | TG Therapeutics, Inc. | 7.71B | 0.06% | 1,285,297 | 799.54M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 7.35B | -2.26% | 1,616,569 | - |
| 37 | IONS | Ionis Pharmaceuticals, Inc. | 7.10B | 0.76% | 2,026,956 | 874.09M |
| 38 | PRAX | Praxis Precision Medicines, Inc. | 6.67B | -1.78% | 852,787 | 7.46M |
| 39 | IOVA | Iovance Biotherapeutics, Inc. | 6.44B | -2.00% | 10,587,612 | 324.97M |
| 40 | BLTE | Belite Bio, Inc | 6.14B | 0.46% | 158,491 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.97B | 0.16% | 583,654 | 239.92M |
| 42 | LGND | Ligand Pharmaceuticals Incorporated | 5.88B | -2.81% | 245,282 | 290.54M |
| 43 | IMVT | Immunovant, Inc. | 5.76B | -2.82% | 1,771,961 | - |
| 44 | CGON | CG Oncology, Inc. | 5.48B | -0.93% | 1,100,414 | 6.23M |
| 45 | MIRM | Mirum Pharmaceuticals, Inc. | 5.18B | 0.28% | 966,728 | 618.07M |
| 46 | ERAS | Erasca, Inc. | 5.14B | -0.54% | 4,747,355 | - |
| 47 | KOD | Kodiak Sciences Inc. | 5.09B | -11.50% | 2,403,729 | - |
| 48 | ORKA | Oruka Therapeutics, Inc. | 5.08B | -1.93% | 685,272 | - |
| 49 | TVTX | Travere Therapeutics, Inc. | 5.02B | 2.84% | 1,624,321 | 591.33M |
| 50 | PTCT | PTC Therapeutics, Inc. | 4.98B | -0.42% | 1,508,992 | 1.01B |
| 51 | COGT | Cogent Biosciences, Inc. | 4.89B | 0.21% | 2,295,156 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 4.86B | 0.24% | 1,701,806 | 13.39M |
| 53 | SRRK | Scholar Rock Holding Corporation | 4.82B | -2.39% | 1,277,723 | - |
| 54 | MANE | Veradermics, Incorporated | 4.74B | -2.40% | 483,508 | - |
| 55 | DFTX | Definium Therapeutics, Inc. | 4.60B | -0.41% | 1,759,752 | - |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.18B | -3.71% | 977,331 | 1.90M |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.02B | 2.04% | 1,345,028 | - |
| 58 | ABCL | AbCellera Biologics Inc. | 4.01B | -1.90% | 3,014,506 | 66.17M |
| 59 | TNGX | Tango Therapeutics, Inc. | 3.74B | -0.09% | 3,436,138 | 53.81M |
| 60 | RLAY | Relay Therapeutics, Inc. | 3.74B | -1.73% | 2,933,638 | 10.35M |
| 61 | LEGN | Legend Biotech Corporation | 3.69B | 6.49% | 3,530,958 | 1.27B |
| 62 | TLX | Telix Pharmaceuticals Limited | 3.54B | -2.47% | 222,586 | 890.79M |
| 63 | ARQT | Arcutis Biotherapeutics, Inc. | 3.32B | 1.23% | 1,624,243 | 463.98M |
| 64 | ACAD | Acadia Pharmaceuticals Inc. | 3.32B | 3.38% | 1,642,692 | 1.14B |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.28B | -1.51% | 1,784,181 | 7.50M |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.27B | -0.93% | 1,059,495 | 234.13M |
| 67 | PBLS | Parabilis Medicines, Inc. | 3.20B | -3.58% | 763,306 | 148.00K |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.17B | 2.08% | 747,703 | 606.33M |
| 69 | VKTX | Viking Therapeutics, Inc. | 2.97B | -4.43% | 6,478,252 | - |
| 70 | CELC | Celcuity Inc. | 2.93B | -5.21% | 2,387,091 | - |
| 71 | ELVN | Enliven Therapeutics, Inc. | 2.88B | -0.56% | 1,217,058 | - |
| 72 | RCUS | Arcus Biosciences, Inc. | 2.87B | 0.09% | 1,194,986 | 117.00M |
| 73 | DNLI | Denali Therapeutics Inc. | 2.86B | -2.88% | 2,703,302 | 3.60M |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.81B | -1.70% | 2,195,888 | - |
| 75 | PGEN | Precigen, Inc. | 2.63B | -1.67% | 3,715,496 | 85.72M |
| 76 | NRIX | Nurix Therapeutics, Inc. | 2.59B | 6.96% | 2,979,651 | 701.94M |
| 77 | ZLAB | Zai Lab Limited | 2.53B | -2.60% | 848,795 | 449.61M |
| 78 | SLS | SELLAS Life Sciences Group, Inc. | 2.40B | -4.27% | 4,190,737 | - |
| 79 | NAMS | NewAmsterdam Pharma Company N.V. | 2.39B | -0.89% | 2,191,245 | 7.12M |
| 80 | BEAM | Beam Therapeutics Inc. | 2.36B | -3.19% | 1,660,427 | 156.04M |
| 81 | MBX | MBX Biosciences, Inc. | 2.35B | -0.39% | 993,886 | - |
| 82 | ADMA | ADMA Biologics, Inc. | 2.32B | 0.29% | 2,412,849 | 512.28M |
| 83 | AUPH | Aurinia Pharmaceuticals Inc. | 2.21B | 1.53% | 1,217,253 | 311.51M |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.19B | -1.47% | 1,044,081 | 158.00K |
| 85 | HRMY | Harmony Biosciences Holdings, Inc. | 2.18B | 1.30% | 921,227 | 959.90M |
| 86 | IRON | Disc Medicine, Inc. | 2.14B | -1.52% | 426,295 | - |
| 87 | PHVS | Pharvaris N.V. | 2.11B | 0.03% | 399,945 | - |
| 88 | NVAX | Novavax, Inc. | 2.08B | -1.40% | 8,049,364 | 413.80M |
| 89 | VRDN | Viridian Therapeutics, Inc. | 2.08B | 0.80% | 3,732,780 | 71.13M |
| 90 | VCEL | Vericel Corporation | 2.06B | -0.12% | 384,548 | 306.30M |
| 91 | FTRE | Fortrea Holdings Inc. | 2.03B | 1.86% | 2,674,062 | 2.68B |
| 92 | ADRX | ADARx Pharmaceuticals, Inc. | 2.01B | 1.36% | 285,471 | 6.13M |
| 93 | RXRX | Recursion Pharmaceuticals, Inc. | 2.01B | -2.48% | 18,508,944 | 54.86M |
| 94 | IMNM | Immunome, Inc. | 1.95B | -2.16% | 911,074 | 4.02M |
| 95 | LKFT | Lakefront Biotherapeutics NV | 1.93B | 1.20% | 226,087 | 1.13B |
| 96 | VERA | Vera Therapeutics, Inc. | 1.93B | -0.17% | 1,527,764 | - |
| 97 | AGIO | Agios Pharmaceuticals, Inc. | 1.85B | 2.42% | 930,894 | 98.34M |
| 98 | MLYS | Mineralys Therapeutics, Inc. | 1.84B | -1.14% | 1,144,929 | - |
| 99 | URGN | UroGen Pharma Ltd. | 1.79B | -4.39% | 1,073,239 | 188.73M |
| 100 | MESO | Mesoblast Limited | 1.79B | -0.76% | 146,468 | 120.25M |
| 101 | SRPT | Sarepta Therapeutics, Inc. | 1.78B | 1.94% | 2,739,631 | 1.97B |
| 102 | PVLA | Palvella Therapeutics, Inc. | 1.77B | -4.61% | 380,261 | - |
| 103 | VIR | Vir Biotechnology, Inc. | 1.76B | -1.89% | 2,759,905 | 303.23M |
| 104 | ZYME | Zymeworks Inc. | 1.76B | -1.20% | 556,570 | 37.13M |
| 105 | XNCR | Xencor, Inc. | 1.74B | -0.55% | 1,368,977 | 104.97M |
| 106 | TRVI | Trevi Therapeutics, Inc. | 1.72B | -1.87% | 2,994,320 | - |
| 107 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.70B | 0.31% | 2,742,520 | 208.78M |
| 108 | SEPN | Septerna, Inc. | 1.70B | -0.26% | 369,977 | 98.88M |
| 109 | BHVN | Biohaven Ltd. | 1.65B | -4.29% | 1,776,817 | - |
| 110 | NUVB | Nuvation Bio Inc. | 1.64B | -0.85% | 3,776,997 | 169.90M |
| 111 | ZBIO | Zenas BioPharma, Inc. | 1.62B | -1.19% | 424,951 | 1.00M |
| 112 | GENB | Generate Biomedicines, Inc. | 1.61B | 2.16% | 1,949,298 | 26.48M |
| 113 | NTLA | Intellia Therapeutics, Inc. | 1.60B | -4.03% | 5,421,313 | 59.51M |
| 114 | OCUL | Ocular Therapeutix, Inc. | 1.58B | -0.55% | 2,197,794 | 52.06M |
| 115 | BRVE | Braveheart Bio, Inc. | 1.57B | -0.26% | 462,840 | - |
| 116 | KRSA | Korsana Biosciences, Inc. | 1.56B | 8.40% | 191,017 | - |
| 117 | GPCR | Structure Therapeutics Inc. | 1.56B | -1.93% | 1,792,479 | - |
| 118 | INVA | Innoviva, Inc. | 1.51B | 1.11% | 673,485 | 440.00M |
| 119 | STOK | Stoke Therapeutics, Inc. | 1.50B | 3.38% | 1,007,495 | 27.59M |
| 120 | ABSI | Absci Corporation | 1.50B | -3.96% | 3,549,055 | 1.56M |
| 121 | RARE | Ultragenyx Pharmaceutical Inc. | 1.46B | -0.13% | 2,952,673 | 717.00M |
| 122 | IMCR | Immunocore Holdings plc | 1.46B | 1.87% | 414,273 | 430.78M |
| 123 | MAZE | Maze Therapeutics, Inc. | 1.46B | -1.61% | 835,693 | 20.00M |
| 124 | QURE | uniQure N.V. | 1.45B | -1.46% | 3,159,230 | 18.67M |
| 125 | COAG | Hemab Therapeutics Holdings, Inc. | 1.40B | 0.47% | 224,940 | - |
| 126 | ANAB | AnaptysBio, Inc. | 1.40B | 2.37% | 494,055 | 106.09M |
| 127 | KLRA | Kailera Therapeutics, Inc. | 1.39B | -0.32% | 1,304,792 | - |
| 128 | RAPP | Rapport Therapeutics, Inc. | 1.36B | -2.28% | 303,995 | 20.00M |
| 129 | AAPG | Ascentage Pharma Group International | 1.34B | -1.39% | 3,372 | 94.61M |
| 130 | OMER | Omeros Corporation | 1.33B | -2.38% | 904,412 | 38.42M |
| 131 | TYRA | Tyra Biosciences, Inc. | 1.29B | 0.75% | 483,996 | - |
| 132 | GHRS | GH Research PLC | 1.27B | -1.59% | 302,642 | - |
| 133 | KARD | Kardigan, Inc. | 1.26B | 4.24% | 826,579 | - |
| 134 | NKTR | Nektar Therapeutics | 1.26B | -2.72% | 709,523 | 54.59M |
| 135 | INBX | Inhibrx Biosciences, Inc. | 1.25B | -2.32% | 245,012 | 1.30M |
| 136 | DRTS | Alpha Tau Medical Ltd. | 1.25B | -1.75% | 420,396 | - |
| 137 | TRAX | First Tracks Biotherapeutics, Inc. | 1.22B | 7.73% | 890,184 | - |
| 138 | SVRA | Savara Inc. | 1.21B | -0.42% | 2,574,246 | - |
| 139 | SNDX | Syndax Pharmaceuticals, Inc. | 1.21B | -3.01% | 3,038,087 | 252.25M |
| 140 | ORIC | ORIC Pharmaceuticals, Inc. | 1.20B | 2.48% | 1,791,321 | - |
| 141 | BCAX | Bicara Therapeutics Inc. | 1.15B | - | 1,428,647 | - |
| 142 | TSHA | Taysha Gene Therapies, Inc. | 1.14B | -1.96% | 3,808,967 | 5.49M |
| 143 | DMRA | Damora Therapeutics, Inc. | 1.14B | -0.70% | 277,550 | - |
| 144 | VOR | Vor Biopharma Inc. | 1.11B | -1.63% | 926,923 | - |
| 145 | LBRX | LB Pharmaceuticals Inc | 1.10B | -2.24% | 362,712 | - |
| 146 | NBTX | Nanobiotix S.A. | 1.09B | -1.07% | 80,556 | 13.15M |
| 147 | REPL | Replimune Group, Inc. | 1.07B | -5.95% | 1,860,296 | - |
| 148 | AVLN | Avalyn Pharma Inc. | 1.05B | -0.21% | 267,752 | - |
| 149 | JANX | Janux Therapeutics, Inc. | 1.05B | -0.29% | 614,590 | 24.00M |
| 150 | MNKD | MannKind Corporation | 971.05M | -0.98% | 7,933,480 | 393.63M |
| 151 | IMTX | Immatics N.V. | 956.83M | 2.49% | 1,541,386 | 47.65M |
| 152 | LTGO | Latigo Biotherapeutics, Inc. | 928.19M | -10.88% | 212,691 | - |
| 153 | AKTS | Aktis Oncology, Inc. | 916.61M | -0.96% | 621,002 | 10.06M |
| 154 | MGTX | MeiraGTx Holdings plc | 904.73M | -5.23% | 1,104,071 | 397.50M |
| 155 | SPTX | Seaport Therapeutics, Inc. | 893.69M | 3.82% | 208,620 | - |
| 156 | SLBT | SL Science Holding Limited | 883.91M | 1.31% | 30,586 | 3.27M |
| 157 | CGEM | Cullinan Therapeutics, Inc. | 878.44M | -3.19% | 903,095 | - |
| 158 | RIGL | Rigel Pharmaceuticals, Inc. | 874.59M | -0.68% | 159,954 | 276.79M |
| 159 | MLTX | MoonLake Immunotherapeutics | 862.98M | -2.59% | 1,772,570 | - |
| 160 | KURA | Kura Oncology, Inc. | 854.91M | -2.24% | 1,444,836 | 77.23M |
| 161 | JBIO | Jade Biosciences, Inc. | 854.75M | 0.15% | 978,296 | - |
| 162 | ANRO | Alto Neuroscience, Inc. | 851.95M | -1.72% | 2,280,072 | - |
| 163 | GLUE | Monte Rosa Therapeutics, Inc. | 838.63M | -0.61% | 1,092,763 | 28.73M |
| 164 | ABUS | Arbutus Biopharma Corporation | 828.98M | 1.95% | 2,432,860 | 181.72M |
| 165 | AVBP | ArriVent BioPharma, Inc. | 800.26M | 0.87% | 1,588,011 | - |
| 166 | ODTX | Odyssey Therapeutics, Inc. | 795.45M | -3.71% | 245,627 | 99.00K |
| 167 | ARDX | Ardelyx, Inc. | 794.91M | 2.24% | 5,822,315 | 450.89M |
| 168 | SGP | SpyGlass Pharma, Inc. | 792.38M | -0.96% | 49,090 | - |
| 169 | CRVS | Corvus Pharmaceuticals, Inc. | 788.63M | -0.37% | 976,000 | - |
| 170 | ALMS | Alumis Inc. | 784.38M | -7.62% | 2,294,716 | 7.40M |
| 171 | DNA | Ginkgo Bioworks Holdings, Inc. | 776.43M | -1.96% | 1,758,113 | 132.42M |
| 172 | GERN | Geron Corporation | 764.54M | -0.83% | 4,822,454 | 204.56M |
| 173 | HELP | Helus Pharma Inc. | 758.36M | -1.14% | 1,050,705 | - |
| 174 | OBX | Obsidian Therapeutics, Inc. | 754.86M | 1.92% | 279,529 | - |
| 175 | ACHV | Achieve Life Sciences, Inc. | 720.32M | - | 1,642,068 | - |
| 176 | APMD | Apnimed, Inc. | 717.30M | -3.37% | 1,012,695 | 115.12M |
| 177 | LXRX | Lexicon Pharmaceuticals, Inc. | 711.93M | -0.62% | 1,901,189 | 41.47M |
| 178 | IMMX | Immix Biopharma, Inc. | 705.50M | -2.07% | 1,360,365 | - |
| 179 | IVA | Inventiva S.A. | 700.35M | - | 3,148,031 | 2.81M |
| 180 | ANL | Adlai Nortye Group Ltd. | 698.72M | -7.70% | 378,002 | 18.06M |
| 181 | VSTM | Verastem, Inc. | 698.24M | 3.49% | 33,733,451 | 87.53M |
| 182 | SANA | Sana Biotechnology, Inc. | 697.51M | -3.32% | 2,411,609 | - |
| 183 | ANNX | Annexon, Inc. | 695.76M | -4.18% | 4,002,252 | - |
| 184 | CADL | Candel Therapeutics, Inc. | 694.02M | -2.16% | 986,716 | - |
| 185 | PHAR | Pharming Group N.V. | 691.51M | 2.12% | 3,948 | 366.48M |
| 186 | GYRE | Gyre Therapeutics, Inc. | 686.04M | -3.58% | 162,848 | 109.82M |
| 187 | MDXG | MiMedx Group, Inc. | 685.07M | 0.21% | 1,635,456 | 355.17M |
| 188 | ATTO | Attovia Therapeutics, Inc. | 682.94M | 1.63% | 359,577 | 1.80M |
| 189 | FDMT | 4D Molecular Therapeutics, Inc. | 673.98M | -1.29% | 632,956 | 92.01M |
| 190 | OABI | OmniAb, Inc. | 661.53M | -3.19% | 737,549 | 38.46M |
| 191 | AURA | Aura Biosciences, Inc. | 639.86M | -1.59% | 1,009,776 | - |
| 192 | AVTX | Avalo Therapeutics, Inc. | 634.98M | -1.42% | 1,234,364 | 59.00K |
| 193 | DSGN | Design Therapeutics, Inc. | 608.92M | -0.51% | 1,046,207 | - |
| 194 | WVE | Wave Life Sciences, Inc. | 608.88M | -1.59% | 2,822,290 | 65.37M |
| 195 | ZVRA | Zevra Therapeutics, Inc. | 607.50M | -1.54% | 752,137 | 136.07M |
| 196 | OLMA | Olema Pharmaceuticals, Inc. | 594.98M | -3.13% | 1,845,264 | - |
| 197 | CLYM | Climb Bio, Inc. | 591.02M | -0.19% | 987,709 | - |
| 198 | PHAT | Phathom Pharmaceuticals, Inc. | 587.78M | 5.71% | 1,721,068 | 239.66M |
| 199 | NVCT | Nuvectis Pharma, Inc. | 587.45M | -0.66% | 184,197 | - |
| 200 | SLDB | Solid Biosciences Inc. | 585.99M | -6.10% | 2,377,903 | - |
| 201 | CRMD | CorMedix Inc. | 576.01M | - | 1,124,883 | 462.25M |
| 202 | ETRA | Electra Therapeutics, Inc. | 558.63M | 3.37% | 520,989 | - |
| 203 | PRME | Prime Medicine, Inc. | 556.84M | -5.72% | 3,782,009 | 4.07M |
| 204 | VALN | Valneva SE | 544.54M | 1.80% | 22,499 | 163.30M |
| 205 | SLN | Silence Therapeutics plc | 540.68M | 1.24% | 1,232,248 | 615.00K |
| 206 | CBIO | Crescent Biopharma, Inc. | 538.44M | -2.56% | 258,089 | 11.88M |
| 207 | SGMT | Sagimet Biosciences Inc. | 535.01M | -5.45% | 1,983,422 | - |
| 208 | STTK | Shattuck Labs, Inc. | 534.94M | -2.91% | 1,082,484 | 1.00M |
| 209 | PBYI | Puma Biotechnology, Inc. | 527.30M | 0.94% | 326,931 | 231.24M |
| 210 | FTH | Faeth Therapeutics, Inc. | 516.81M | -7.02% | 421,404 | - |
| 211 | DBVT | DBV Technologies S.A. | 516.30M | -1.77% | 351,199 | 5.04M |
| 212 | DRUG | Bright Minds Biosciences Inc. | 511.90M | -1.27% | 199,353 | - |
| 213 | ACRS | Aclaris Therapeutics, Inc. | 497.53M | -2.59% | 1,881,415 | 8.22M |
| 214 | MNPR | Monopar Therapeutics Inc. | 490.66M | 1.42% | 104,678 | - |
| 215 | CTMX | CytomX Therapeutics, Inc. | 485.92M | -4.09% | 3,350,872 | 18.30M |
| 216 | BLSM | BlossomHill Therapeutics, Inc. | 485.04M | -1.42% | 164,545 | - |
| 217 | RGNX | REGENXBIO Inc. | 454.17M | -5.23% | 1,557,940 | 174.48M |
| 218 | YDES | YD Bio Limited | 450.49M | 4.26% | 20,276 | 1.24M |
| 219 | AUTL | Autolus Therapeutics plc | 449.81M | 4.32% | 2,583,297 | 117.39M |
| 220 | ALT | Altimmune, Inc. | 449.34M | -4.94% | 5,615,552 | 31.00K |
| 221 | ALLO | Allogene Therapeutics, Inc. | 449.14M | 0.78% | 7,729,445 | 4.64M |
| 222 | ARVN | Arvinas, Inc. | 445.93M | -0.29% | 856,959 | 316.70M |
| 223 | NGNE | Neurogene Inc. | 443.85M | 2.88% | 522,412 | 925.00K |
| 224 | RZLT | Rezolute, Inc. | 443.71M | -8.24% | 1,691,686 | - |
| 225 | PROK | ProKidney Corp. | 442.90M | -6.69% | 2,120,512 | 818.00K |
| 226 | OCS | Oculis Holding AG | 442.62M | -5.91% | 475,685 | 1.45M |
| 227 | EPRX | Eupraxia Pharmaceuticals Inc. | 438.91M | -1.35% | 276,010 | - |
| 228 | ENTX | Entera Bio Ltd. | 434.81M | 0.40% | 772,940 | 42.00K |
| 229 | MPLT | MapLight Therapeutics, Inc. | 434.60M | -0.70% | 450,915 | - |
| 230 | PRTA | Prothena Corporation plc | 429.69M | 0.12% | 618,305 | 54.53M |
| 231 | OVID | Ovid Therapeutics Inc. | 427.70M | - | 1,637,841 | 1.58M |
| 232 | AGMB | AgomAb Therapeutics NV | 425.50M | -1.93% | 57,697 | - |
| 233 | ZURA | Zura Bio Limited | 422.61M | 4.26% | 5,505,893 | - |
| 234 | DMAC | DiaMedica Therapeutics Inc. | 421.70M | -2.05% | 286,957 | - |
| 235 | ASMB | Assembly Biosciences, Inc. | 418.41M | 1.03% | 240,762 | 74.85M |
| 236 | TECX | Tectonic Therapeutic, Inc. | 409.56M | -1.69% | 190,774 | - |
| 237 | SCTX | Scribe Therapeutics Inc. | 393.21M | 8.63% | 390,575 | 33.30M |
| 238 | SPRY | ARS Pharmaceuticals, Inc. | 391.82M | -2.72% | 1,728,590 | 116.93M |
| 239 | CAPR | Capricor Therapeutics, Inc. | 383.14M | -4.22% | 2,288,188 | 11.13M |
| 240 | EIKN | Eikon Therapeutics, Inc. | 379.70M | 4.32% | 595,508 | - |
| 241 | AVIR | Atea Pharmaceuticals, Inc. | 370.55M | -7.23% | 414,458 | - |
| 242 | GALT | Galectin Therapeutics Inc. | 367.09M | -1.36% | 408,960 | - |
| 243 | TRXB | TRex Bio, Inc. | 363.45M | -0.74% | 398,813 | - |
| 244 | KYTX | Kyverna Therapeutics, Inc. | 351.58M | -1.47% | 987,526 | - |
| 245 | FENC | Fennec Pharmaceuticals Inc. | 349.97M | -1.96% | 207,584 | 59.22M |
| 246 | EDIT | Editas Medicine, Inc. | 348.63M | -7.16% | 2,823,614 | 47.01M |
| 247 | RLMD | Relmada Therapeutics, Inc. | 345.61M | -3.57% | 1,354,315 | - |
| 248 | VTVT | vTv Therapeutics Inc. | 344.04M | -1.91% | 20,138 | 36.84M |
| 249 | IRD | Opus Genetics, Inc. | 341.10M | -3.30% | 1,197,380 | 9.86M |
| 250 | OBIO | Orchestra BioMed Holdings, Inc. | 338.99M | -1.40% | 222,882 | 31.98M |
| 251 | PRLD | Prelude Therapeutics Incorporated | 331.13M | -9.69% | 488,299 | 22.42M |
| 252 | TTRX | Turn Therapeutics Inc. | 328.26M | 3.96% | 53,364 | - |
| 253 | IKT | Inhibikase Therapeutics, Inc. | 327.73M | 2.27% | 1,578,785 | 1.00 |
| 254 | ENTA | Enanta Pharmaceuticals, Inc. | 325.62M | -2.95% | 227,614 | 65.26M |
| 255 | CCCC | C4 Therapeutics, Inc. | 321.10M | -6.12% | 3,093,380 | 35.04M |
| 256 | ARCT | Arcturus Therapeutics Holdings Inc. | 316.06M | -7.56% | 588,757 | 29.37M |
| 257 | CTNM | Contineum Therapeutics, Inc. | 306.24M | -3.33% | 824,635 | - |
| 258 | INDP | Indaptus Therapeutics, Inc. | 297.13M | -6.69% | 449,822 | - |
| 259 | AGEN | Agenus Inc. | 292.63M | -6.47% | 979,195 | 132.69M |
| 260 | BNTC | Benitec Biopharma Inc. | 289.18M | -3.94% | 162,498 | - |
| 261 | ARTV | Artiva Biotherapeutics, Inc. | 288.94M | -6.04% | 706,107 | 251.00K |
| 262 | OCGN | Ocugen, Inc. | 285.26M | -4.99% | 9,251,191 | 4.58M |
| 263 | FULC | Fulcrum Therapeutics, Inc. | 280.39M | -0.14% | 1,661,189 | 80.00M |
| 264 | SRZN | Surrozen, Inc. | 279.15M | 1.02% | 631,176 | 11.51M |
| 265 | NAUT | Nautilus Biotechnology, Inc. | 274.87M | 5.37% | 7,962,120 | 190.00K |
| 266 | CABA | Cabaletta Bio, Inc. | 274.66M | -4.14% | 5,942,230 | - |
| 267 | CUVL | Clinuvel Pharmaceuticals Limited | 260.16M | -2.61% | 3,269 | 65.05M |
| 268 | EYPT | EyePoint, Inc. | 259.50M | -1.95% | 3,155,855 | 2.79M |
| 269 | PALI | Palisade Bio, Inc. | 257.92M | 1.02% | 4,064,236 | 500.00K |
| 270 | VNDA | Vanda Pharmaceuticals Inc. | 255.15M | -1.86% | 848,049 | 215.72M |
| 271 | VCRE | Vicore Pharma Holding AB (publ) | 254.71M | 1.45% | 23,096 | 412.09K |
| 272 | IPSC | Century Therapeutics, Inc. | 249.88M | - | 1,271,341 | 109.16M |
| 273 | ABEO | Abeona Therapeutics Inc. | 249.32M | -3.54% | 1,666,862 | 25.52M |
| 274 | BCYC | Bicycle Therapeutics plc | 245.67M | -3.31% | 424,106 | 61.21M |
| 275 | XFOR | X4 Pharmaceuticals, Inc. | 242.91M | -5.58% | 703,543 | 15.85M |
| 276 | RCKT | Rocket Pharmaceuticals, Inc. | 242.60M | -3.91% | 2,007,301 | - |
| 277 | ACIU | AC Immune SA | 239.62M | 0.42% | 209,721 | 21.67M |
| 278 | VOGX | Vogenx, Inc. | 239.17M | -3.94% | 91,446 | - |
| 279 | QTTB | Q32 Bio Inc. | 238.45M | -0.62% | 889,287 | 53.74M |
| 280 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 233.31M | -1.36% | 440,591 | - |
| 281 | FATE | Fate Therapeutics, Inc. | 232.45M | -3.00% | 1,586,329 | 6.49M |
| 282 | LCTX | Lineage Cell Therapeutics, Inc. | 232.04M | 1.01% | 2,181,789 | 13.08M |
| 283 | SLGL | Sol-Gel Technologies Ltd. | 227.58M | 1.77% | 24,133 | 1.80M |
| 284 | SABS | SAB Biotherapeutics, Inc. | 226.56M | -7.09% | 853,129 | 114.70K |
| 285 | GLSI | Greenwich LifeSciences, Inc. | 226.04M | -0.65% | 137,805 | - |
| 286 | IMRX | Immuneering Corporation | 221.27M | -3.93% | 802,903 | - |
| 287 | ZNTL | Zentalis Pharmaceuticals, Inc. | 219.64M | -3.33% | 862,842 | 26.87M |
| 288 | LRMR | Larimar Therapeutics, Inc. | 219.20M | -2.78% | 2,255,741 | - |
| 289 | KROS | Keros Therapeutics, Inc. | 219.09M | -1.60% | 159,035 | 15.01M |
| 290 | IFRX | InflaRx N.V. | 218.10M | -4.52% | 585,627 | -11.54K |
| 291 | LXEO | Lexeo Therapeutics, Inc. | 215.77M | -4.01% | 1,923,257 | - |
| 292 | CAMP | Camp4 Therapeutics Corporation | 215.24M | - | 155,715 | 4.22M |
| 293 | PYXS | Pyxis Oncology, Inc. | 213.83M | -3.24% | 1,558,043 | 11.04M |
| 294 | MGNX | MacroGenics, Inc. | 210.85M | -3.22% | 906,742 | 175.14M |
| 295 | PLX | Protalix BioTherapeutics, Inc. | 210.29M | -5.09% | 1,532,112 | 80.62M |
| 296 | ALEC | Alector, Inc. | 209.92M | 0.53% | 2,438,467 | 13.86M |
| 297 | EVMN | Evommune, Inc. | 209.41M | -1.87% | 574,828 | 10.00M |
| 298 | PRQR | ProQR Therapeutics N.V. | 208.86M | - | 1,082,277 | 21.05M |
| 299 | LYEL | Lyell Immunopharma, Inc. | 195.31M | 6.13% | 402,232 | 27.00K |
| 300 | RNAC | Cartesian Therapeutics, Inc. | 191.82M | -3.50% | 163,985 | 1.48M |
| 301 | CGEN | Compugen Ltd. | 189.45M | 1.01% | 378,101 | 74.00M |
| 302 | ACOG | Alpha Cognition Inc. | 188.38M | -1.70% | 73,656 | 15.26M |
| 303 | UPB | Upstream Bio, Inc. | 187.32M | -3.66% | 1,572,452 | 3.16M |
| 304 | SION | Sionna Therapeutics, Inc. | 184.92M | -6.62% | 1,497,672 | - |
| 305 | ELDN | Eledon Pharmaceuticals, Inc. | 183.02M | -3.85% | 986,788 | - |
| 306 | IVVD | Invivyd, Inc. | 179.15M | -5.91% | 3,881,715 | 58.37M |
| 307 | YARW | Yarrow Bioscience, Inc. | 175.85M | 1.61% | 105,561 | - |
| 308 | STRO | Sutro Biopharma, Inc. | 174.43M | -4.45% | 452,969 | 45.70M |
| 309 | ORMP | Oramed Pharmaceuticals Inc. | 172.21M | -0.72% | 145,776 | 2.00M |
| 310 | WHWK | Whitehawk Therapeutics, Inc. | 169.32M | -1.66% | 510,062 | 7.15M |
| 311 | NGEN | NervGen Pharma Corp. | 168.27M | -3.99% | 686,927 | - |
| 312 | DTIL | Precision BioSciences, Inc. | 166.44M | -1.15% | 293,394 | 45.06M |
| 313 | TRDA | Entrada Therapeutics, Inc. | 164.06M | -6.38% | 738,321 | 4.69M |
| 314 | CHRS | Coherus Oncology, Inc. | 162.23M | -1.87% | 1,716,202 | 50.94M |
| 315 | PEPG | PepGen Inc. | 161.03M | -7.00% | 917,340 | - |
| 316 | CMPX | Compass Therapeutics, Inc. | 158.30M | 2.57% | 4,967,662 | 850.00K |
| 317 | VRXA | Veraxa Biotech AG | 156.96M | -7.50% | 61,169 | 29.54K |
| 318 | ADAG | Adagene Inc. | 153.76M | -6.91% | 898,862 | 9.29M |
| 319 | MDWD | MediWound Ltd. | 153.63M | -2.62% | 91,818 | 11.86M |
| 320 | MENS | Jyong Biotech Ltd. | 152.18M | 0.49% | 32,829 | - |
| 321 | NBP | NovaBridge Biosciences | 148.48M | -0.78% | 410,056 | - |
| 322 | TARA | Protara Therapeutics, Inc. | 146.56M | -5.34% | 640,568 | - |
| 323 | CNTN | Canton Strategic Holdings, Inc. | 146.22M | -9.16% | 980,617 | 1.50M |
| 324 | NKTX | Nkarta, Inc. | 145.40M | -3.33% | 701,806 | - |
| 325 | CDXS | Codexis, Inc. | 141.26M | -2.27% | 854,280 | 77.68M |
| 326 | MOLN | Molecular Partners AG | 139.85M | -0.54% | 3,304 | 856.30K |
| 327 | AVXL | Anavex Life Sciences Corp. | 138.12M | 0.68% | 1,226,130 | - |
| 328 | MSLE | Satellos Bioscience Inc. | 136.72M | -7.53% | 40,711 | - |
| 329 | CUE | Cue Biopharma, Inc. | 135.12M | -4.96% | 244,933 | 37.66M |
| 330 | TLSA | Tiziana Life Sciences Ltd | 134.48M | -4.59% | 581,347 | - |
| 331 | ANTX | AN2 Therapeutics, Inc. | 133.59M | -1.67% | 431,025 | - |
| 332 | RNA | Atrium Therapeutics, Inc. | 131.37M | -0.90% | 269,490 | 35.84M |
| 333 | KRRO | Korro Bio, Inc. | 130.76M | 0.79% | 216,391 | 2.38M |
| 334 | IPHA | Innate Pharma S.A. | 127.96M | -2.72% | 8,161 | 11.21M |
| 335 | ABOS | Acumen Pharmaceuticals, Inc. | 126.19M | -3.86% | 597,012 | - |
| 336 | VYGR | Voyager Therapeutics, Inc. | 123.85M | -6.51% | 1,099,057 | 34.46M |
| 337 | ALXO | ALX Oncology Holdings Inc. | 123.72M | -8.67% | 2,567,847 | - |
| 338 | SEER | Seer, Inc. | 115.17M | -1.42% | 79,123 | 14.22M |
| 339 | OTLK | Outlook Therapeutics, Inc. | 114.47M | -16.60% | 9,473,595 | -1.16M |
| 340 | NERV | Minerva Neurosciences, Inc. | 112.21M | -6.56% | 254,221 | - |
| 341 | HURA | TuHURA Biosciences, Inc. | 112.16M | -2.76% | 144,930 | - |
| 342 | NRXP | NRx Pharmaceuticals, Inc. | 112.05M | -4.07% | 693,633 | 3.39M |
| 343 | SPRB | Spruce Biosciences, Inc. | 112.03M | -3.40% | 112,683 | 697.00K |
| 344 | FHTX | Foghorn Therapeutics Inc. | 110.46M | 0.54% | 1,071,663 | 36.74M |
| 345 | CBUS | Cibus, Inc. | 110.06M | 2.13% | 106,575 | 4.35M |
| 346 | TNXP | Tonix Pharmaceuticals Holding Corp. | 109.77M | 4.40% | 1,386,873 | 29.10M |
| 347 | MIST | Milestone Pharmaceuticals Inc. | 108.50M | 0.55% | 806,141 | 2.34M |
| 348 | LENZ | LENZ Therapeutics, Inc. | 107.77M | 0.88% | 931,209 | 21.48M |
| 349 | VANI | Vivani Medical, Inc. | 104.64M | -1.69% | 134,910 | - |
| 350 | ENGN | enGene Therapeutics Inc. | 104.55M | -4.29% | 942,931 | - |
| 351 | GNLX | Genelux Corporation | 103.96M | -7.94% | 409,817 | 8.00K |
| 352 | ARMP | Armata Pharmaceuticals, Inc. | 103.37M | -10.32% | 125,518 | 5.54M |
| 353 | UNCY | Unicycive Therapeutics, Inc. | 103.06M | -0.80% | 1,144,228 | - |
| 354 | CNXU | Conexeu Sciences Inc. | 102.39M | 10.12% | 1,145,323 | - |
| 355 | TVGN | Tevogen Inc. | 102.38M | -8.50% | 2,486 | - |
| 356 | PDSB | PDS Biotechnology Corporation | 102.19M | -11.88% | 9,273,887 | - |
| 357 | INO | Inovio Pharmaceuticals, Inc. | 101.95M | -1.22% | 2,972,267 | 65.34K |
| 358 | HUMA | Humacyte, Inc. | 98.37M | -1.34% | 5,412,848 | 2.12M |
| 359 | COYA | Coya Therapeutics, Inc. | 98.29M | -6.37% | 257,407 | 8.02M |
| 360 | PLYX | Polaryx Therapeutics, Inc. | 98.20M | 1.55% | 16,602 | - |
| 361 | BDTX | Black Diamond Therapeutics, Inc. | 97.67M | 1.19% | 1,068,479 | 70.00M |
| 362 | ICCC | ImmuCell Corporation | 97.63M | -0.37% | 9,370 | 30.68M |
| 363 | RTSN | Retension Pharmaceuticals, Inc. | 96.98M | 0.09% | 77,189 | - |
| 364 | PYPD | PolyPid Ltd. | 96.89M | -2.25% | 132,774 | - |
| 365 | ATRA | Atara Biotherapeutics, Inc. | 95.96M | 2.74% | 39,511 | 6.19M |
| 366 | PMVP | PMV Pharmaceuticals, Inc. | 93.64M | -8.15% | 525,702 | - |
| 367 | RANI | Rani Therapeutics Holdings, Inc. | 93.42M | -8.59% | 1,182,576 | 4.88M |
| 368 | KZIA | Kazia Therapeutics Limited | 93.05M | -15.55% | 825,274 | 1.27M |
| 369 | ANIX | Anixa Biosciences, Inc. | 92.30M | -0.56% | 228,408 | - |
| 370 | OKUR | OnKure Therapeutics, Inc. | 91.12M | -4.05% | 381,167 | - |
| 371 | IMUX | Immunic, Inc. | 90.87M | -3.34% | 437,782 | - |
| 372 | RLYB | Rallybio Corporation | 89.00M | 0.24% | 5,124 | 646.00K |
| 373 | CLLS | Cellectis S.A. | 88.18M | 1.73% | 97,819 | 63.82M |
| 374 | TENX | Tenax Therapeutics, Inc. | 87.93M | -4.06% | 1,784,750 | - |
| 375 | TNYA | Tenaya Therapeutics, Inc. | 87.56M | -25.05% | 18,041,902 | 1.34M |
| 376 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 85.30M | -7.74% | 1,293,327 | - |
| 377 | AARD | Aardvark Therapeutics, Inc. | 84.48M | -4.46% | 126,111 | - |
| 378 | EQ | Equillium, Inc. | 82.43M | -1.52% | 263,621 | 4.39M |
| 379 | NRXS | NeurAxis, Inc. | 82.00M | 0.46% | 171,959 | 5.32M |
| 380 | PTHS | Pelthos Therapeutics Inc. | 77.53M | -0.20% | 44,471 | 43.30M |
| 381 | TELO | Telomir Pharmaceuticals, Inc. | 77.30M | -3.67% | 86,719 | - |
| 382 | NTRB | Nutriband Inc. | 76.82M | -3.07% | 51,696 | 1.62M |
| 383 | CRDF | Cardiff Oncology, Inc. | 75.83M | -3.49% | 412,793 | 508.00K |
| 384 | PMN | ProMIS Neurosciences, Inc. | 74.30M | -4.33% | 23,366 | - |
| 385 | OKYO | OKYO Pharma Limited | 74.26M | -1.57% | 18,458 | - |
| 386 | CGTX | Cognition Therapeutics, Inc. | 73.86M | -3.12% | 516,540 | - |
| 387 | ACRV | Acrivon Therapeutics, Inc. | 73.71M | -1.71% | 214,531 | - |
| 388 | MNOV | MediciNova, Inc. | 71.86M | -2.67% | 96,185 | 920.48K |
| 389 | HRTX | Heron Therapeutics, Inc. | 68.73M | -7.32% | 2,086,493 | 151.18M |
| 390 | ONCY | Oncolytics Biotech Inc. | 68.63M | 9.84% | 3,016,291 | - |
| 391 | MAIA | MAIA Biotechnology, Inc. | 68.12M | -3.45% | 628,601 | - |
| 392 | CSBR | Champions Oncology, Inc. | 66.95M | -1.84% | 2,921 | 60.66M |
| 393 | NMRA | Neumora Therapeutics, Inc. | 66.61M | -4.24% | 2,797,133 | - |
| 394 | XBIT | XBiotech Inc. | 66.46M | 0.93% | 66,074 | - |
| 395 | CING | Cingulate Inc. | 66.46M | -3.18% | 102,589 | - |
| 396 | NTHI | NeOnc Technologies Holdings, Inc. | 66.12M | 2.50% | 133,229 | 39.99K |
| 397 | VRCA | Verrica Pharmaceuticals Inc. | 65.79M | 6.98% | 53,953 | 30.32M |
| 398 | SPRO | Spero Therapeutics, Inc. | 64.64M | -3.48% | 695,673 | 47.00M |
| 399 | HYFT | MindWalk Holdings Corp. | 64.54M | -7.43% | 291,982 | 11.57M |
| 400 | OSTX | OS Therapies Incorporated | 64.11M | -4.14% | 484,987 | - |
| 401 | FBIO | Fortress Biotech, Inc. | 63.37M | -2.56% | 376,050 | 68.47M |
| 402 | BMEA | Biomea Fusion, Inc. | 60.45M | -33.81% | 11,534,804 | - |
| 403 | XLO | Xilio Therapeutics, Inc. | 59.22M | -2.39% | 12,420 | 64.09M |
| 404 | ALPS | Alps Group Inc | 58.22M | -0.03% | 50,623 | 3.74M |
| 405 | GANX | Gain Therapeutics, Inc. | 57.61M | -6.38% | 849,231 | - |
| 406 | CNTB | Connect Biopharma Holdings Limited | 57.24M | -1.07% | 1,079,873 | 2.95M |
| 407 | PLRX | Pliant Therapeutics, Inc. | 54.73M | -8.69% | 978,408 | - |
| 408 | GOSS | Gossamer Bio, Inc. | 54.47M | -8.76% | 360,402 | 53.29M |
| 409 | BOLD | Boundless Bio, Inc. | 54.36M | -1.65% | 127,392 | - |
| 410 | GUTS | Fractyl Health, Inc. | 54.12M | 1.37% | 188,988 | 3.00K |
| 411 | INKT | MiNK Therapeutics, Inc. | 52.82M | 1.17% | 5,934 | - |
| 412 | ACET | Adicet Bio, Inc. | 52.64M | -4.31% | 357,656 | - |
| 413 | ELOX | Eloxx Pharmaceuticals, Inc. | 51.55M | 0.55% | 12,445 | - |
| 414 | ATHE | Alterity Therapeutics Limited | 50.91M | -1.40% | 53,247 | 2.50M |
| 415 | LONA | LeonaBio, Inc. | 50.78M | -16.17% | 102,828 | - |
| 416 | KLRS | Kalaris Therapeutics, Inc. | 50.70M | -4.48% | 20,953 | - |
| 417 | RNTX | Rein Therapeutics Inc. | 50.55M | -22.34% | 1,102,486 | - |
| 418 | RNXT | RenovoRx, Inc. | 50.55M | -2.61% | 624,370 | 1.98M |
| 419 | IBIO | iBio, Inc. | 50.21M | -0.13% | 1,433,000 | 100.00K |
| 420 | MREO | Mereo BioPharma Group plc | 49.42M | -3.28% | 881,122 | 500.00K |
| 421 | CRBU | Caribou Biosciences, Inc. | 49.33M | -2.11% | 3,701,996 | 10.04M |
| 422 | HYPD | Hyperion DeFi, Inc. | 48.02M | -8.04% | 742,644 | 1.40M |
| 423 | APLM | Apollomics, Inc. | 47.81M | 2.11% | 2,034 | 8.84M |
| 424 | ALDX | Aldeyra Therapeutics, Inc. | 47.68M | -12.16% | 1,560,387 | - |
| 425 | HOWL | Werewolf Therapeutics, Inc. | 47.63M | -1.12% | 651,934 | 21.00M |
| 426 | ELTX | Elicio Therapeutics, Inc. | 47.18M | 1.41% | 373,247 | - |
| 427 | IMA | ImageneBio, Inc. | 47.11M | -2.11% | 20,683 | 800.00K |
| 428 | CLNN | Clene Inc. | 47.05M | -2.36% | 71,314 | 197.00K |
| 429 | INMB | INmune Bio Inc. | 44.41M | -4.76% | 1,125,403 | 50.00K |
| 430 | ANVS | Annovis Bio, Inc. | 43.46M | -3.77% | 843,701 | - |
| 431 | SER | Serina Therapeutics, Inc. | 43.43M | -6.04% | 41,220 | 130.00K |
| 432 | DWTX | Dogwood Therapeutics, Inc. | 43.17M | -2.31% | 82,974 | - |
| 433 | EXOZ | eXoZymes, Inc. | 42.69M | 0.22% | 7,584 | -700.00 |
| 434 | CELU | Celularity Inc. | 42.51M | -7.75% | 79,790 | 18.97M |
| 435 | TIL | Instil Bio, Inc. | 40.35M | -3.72% | 44,119 | - |
| 436 | GRCE | Grace Therapeutics, Inc. | 39.86M | -4.77% | 177,832 | - |
| 437 | BSEM | BioStem Technologies, Inc. | 39.21M | -6.22% | 69,783 | 34.59M |
| 438 | VERU | Veru Inc. | 36.32M | -2.74% | 268,780 | 16.89M |
| 439 | EDSA | Edesa Biotech, Inc. | 35.81M | -6.85% | 72,563 | - |
| 440 | LITS | Lite Strategy, Inc. | 35.58M | -3.31% | 277,983 | - |
| 441 | FLNA | Filana Therapeutics, Inc. | 35.34M | -1.59% | 251,835 | - |
| 442 | CRVO | CervoMed Inc. | 34.62M | 0.88% | 489,162 | 331.30K |
| 443 | NNVC | NanoViricides, Inc. | 33.44M | -0.76% | 146,706 | - |
| 444 | ALGS | Aligos Therapeutics, Inc. | 32.72M | -4.90% | 60,553 | 31.52M |
| 445 | MGX | Metagenomi Therapeutics, Inc. | 32.53M | -6.13% | 285,810 | 13.56M |
| 446 | BCTX | BriaCell Therapeutics Corp. | 32.34M | -0.54% | 50,262 | - |
| 447 | ATNM | Actinium Pharmaceuticals, Inc. | 30.64M | -2.49% | 83,454 | 35.09M |
| 448 | IRLA | IRulya Therapeutics Inc. | 30.51M | 7.64% | 26,689 | - |
| 449 | GRDX | GridAI Technologies Corp. | 30.09M | -6.59% | 62,253 | - |
| 450 | CVM | CEL-SCI Corporation | 30.08M | -2.29% | 105,675 | - |
| 451 | NXTC | NextCure, Inc. | 29.75M | 3.50% | 51,596 | - |
| 452 | RNAZ | TransCode Therapeutics, Inc. | 29.29M | 2.98% | 42,830 | - |
| 453 | IBO | Impact BioMedical Inc. | 29.08M | -14.49% | 3,812 | 35.00K |
| 454 | ATOS | Atossa Therapeutics, Inc. | 27.74M | 8.59% | 235,881 | - |
| 455 | ABVC | ABVC BioPharma, Inc. | 26.44M | 4.19% | 55,896 | 797.92K |
| 456 | IGC | IGC Pharma, Inc. | 26.04M | -4.94% | 916,675 | 1.11M |
| 457 | PLRZ | Polyrizon Ltd. | 25.28M | 6.88% | 90,114 | - |
| 458 | IMMP | Immutep Limited | 24.36M | -5.32% | 38,701 | 13.79M |
| 459 | MCRB | Seres Therapeutics, Inc. | 24.31M | -4.35% | 41,919 | 1.88M |
| 460 | BYSI | BeyondSpring Inc. | 24.14M | -3.25% | 35,765 | 1.88M |
| 461 | CNTX | Context Therapeutics Inc. | 23.62M | -6.51% | 949,989 | - |
| 462 | EVAX | Evaxion A/S | 23.35M | 1.45% | 50,394 | 7.49M |
| 463 | KYNB | Kyntra Bio, Inc. | 22.53M | -5.20% | 36,649 | 4.62M |
| 464 | QNTM | Quantum BioPharma Ltd. | 21.84M | -6.57% | 180,060 | - |
| 465 | COCP | Cocrystal Pharma, Inc. | 20.03M | -3.70% | 45,041 | 330.00K |
| 466 | QNRX | Quoin Pharmaceuticals, Ltd. | 19.70M | -1.20% | 159,065 | - |
| 467 | ATYR | aTyr Pharma, Inc. | 17.98M | -8.85% | 2,546,413 | 190.00K |
| 468 | NEUP | Neuphoria Therapeutics Inc. | 17.53M | -4.42% | 44,078 | 1.17M |
| 469 | JSPR | Jasper Therapeutics, Inc. | 16.67M | 1.09% | 620,088 | - |
| 470 | AKTX | Akari Therapeutics, Plc | 16.64M | -7.85% | 34,875 | - |
| 471 | ICU | SeaStar Medical Holding Corporation | 15.84M | -16.16% | 500,310 | 1.71M |
| 472 | PBM | Psyence Biomedical Ltd. | 15.75M | -9.23% | 68,189 | - |
| 473 | KPRX | Kiora Pharmaceuticals, Inc. | 15.72M | - | 18,231 | 20.00K |
| 474 | NCEL | NewcelX Ltd. | 15.08M | -8.10% | 9,296 | - |
| 475 | DYAI | Dyadic International, Inc. | 14.95M | -3.55% | 35,957 | 3.80M |
| 476 | MRKR | Marker Therapeutics, Inc. | 14.84M | -3.75% | 65,169 | 3.55M |
| 477 | PTN | Palatin Technologies, Inc. | 14.67M | -9.40% | 49,230 | 13.19M |
| 478 | DARE | Daré Bioscience, Inc. | 14.34M | -2.50% | 60,882 | 1.37M |
| 479 | TCRX | TScan Therapeutics, Inc. | 14.27M | -2.81% | 545,526 | 7.11M |
| 480 | RADX | Radiopharm Theranostics Limited | 14.14M | -6.66% | 38,289 | 8.90M |
| 481 | BCDA | BioCardia, Inc. | 14.04M | -6.37% | 144,681 | 3.00K |
| 482 | LPCN | Lipocine Inc. | 13.93M | 4.32% | 357,884 | 1.57M |
| 483 | ALLR | Allarity Therapeutics, Inc. | 13.89M | 0.39% | 56,264 | 345.00K |
| 484 | ESLA | Estrella Immunopharma, Inc. | 13.83M | 1.24% | 176,708 | - |
| 485 | KTTA | Pasithea Therapeutics Corp. | 13.68M | -3.40% | 616,470 | - |
| 486 | HIND | Vyome Holdings, Inc. | 13.55M | -2.03% | 6,340 | 129.73K |
| 487 | TVRD | Tvardi Therapeutics, Inc. | 13.34M | -3.85% | 74,463 | - |
| 488 | CNSY | Cerenome, Inc. | 12.83M | -2.87% | 82,058 | 4.20M |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 12.77M | -2.31% | 233,192 | 7.11M |
| 490 | INAB | IN8bio, Inc. | 11.93M | 2.54% | 73,586 | - |
| 491 | PASG | Passage Bio, Inc. | 11.78M | 0.55% | 7,621 | - |
| 492 | PLUR | Pluri Inc. | 11.48M | -1.06% | 4,820 | 1.02M |
| 493 | AEON | AEON Biopharma, Inc. | 11.42M | -0.35% | 1,115,695 | - |
| 494 | INTS | Intensity Therapeutics, Inc. | 11.23M | -3.14% | 25,138 | - |
| 495 | GTBP | GT Biopharma, Inc. | 11.21M | -4.46% | 41,769 | - |
| 496 | CLRB | Cellectar Biosciences, Inc. | 11.15M | -15.11% | 392,033 | - |
| 497 | PHIO | Phio Pharmaceuticals Corp. | 11.03M | 1.62% | 132,193 | - |
| 498 | ENSC | Ensysce Biosciences, Inc. | 10.92M | -2.01% | 411,469 | 4.50M |
| 499 | TPST | Tempest Therapeutics, Inc. | 10.51M | -6.77% | 178,886 | - |
| 500 | ACTU | Actuate Therapeutics, Inc. | 10.43M | -6.88% | 438,492 | - |